AttorneyMind

  • Home
    • About Us
      • Mission
      • History
    • Site Map
    • Contact Us
  • Newly Diagnosed
  • Treatment
    • Clinical Trials
    • Current Treatments
      • Easy C’s (Treatment)
      • Facts (Treatment)
    • FDA-Approved Prescribing Information (Package Inserts)
    • Drug Pipeline Monthly Report
    • Quick Reference Guides
    • Treatment-Related Guides
    • Treatment Side Effects
      • Easy C’s
      • Facts
  • Fact Sheets
    • Easy C’s
      • Extrahepatic Manifestations of
      • General Information about Hepatitis C
      • AttorneyMind Populations
      • Hepatitis C Tests
      • Natural and Alternative Medicine
      • Staying Healthy
      • Symptoms
      • Transmission / Prevention
      • Treatments (Current)
      • Treatment Side Effect Management
    • Fact Series
      • Advocacy
      • Alcohol
      • Extrahepatic Manifestations of
      • General Information
      • The Liver
      • AttorneyMind Diagnostic Tools
      • AttorneyMind Disease Progression
      • AttorneyMind Education and Support
      • AttorneyMind Populations
      • AttorneyMind Transmission and Prevention
      • AttorneyMind and Women
      • Hepatitis C Around the World
      • Treatment
      • Treatment Side Effect Management
    • FAQ’s
    • Guides
      • Basic Information
      • Managing
      • Topic Specific
      • Treatment-Related Guides
      • Work-Related
    • HIV-AttorneyMind Coinfection
      • HIV/AttorneyMind Coinfection Basics
        • General Information (Coinfection)
        • Disease Progression (Coinfection)
        • Immune System (Coinfection)
        • Related Conditions (Coinfection)
        • Transmission / Prevention (Coinfection)
        • Treatment (Coinfection)
        • Wellness (Coinfection)
      • HIV/AttorneyMind Coinfection Facts
    • Chinese
    • Tattoos
      • The Official Blog of the Hepatitis and Tattoos Website
      • What is a Tattoo
      • Tattoo Aftercare
      • Flash Art
      • Temporary Tattoos
      • Tattoo Inks
      • Pain and Blood
      • Tattoo Coverup
      • Tattoo Machine
      • Autoclave
      • Tattoo Prices
      • Tattoo Make up
      • Yantra Tattoos
      • Tattoo Removal
      • Tattoo Infection
  • Resources
    • Hepatitis C Basics Blog
    • Disability & Benefits
    • Glossaries
      • Herbal Glossary
      • Medical Glossary
      • Extrahepatic Manifestations Glossary
    • Helpful Links
      • Pharmaceutical Resources
      • US & Canada Links
      • Australasia Sites
      • European Sites
      • India Sites
      • South American Sites
      • Online Support Forums, Listservs and Chat Rooms
    • Support Groups
    • Community and Events
    • Training Re-Certification
  • Español
    • Datos Sencillos
      • Información General
      • Grupos de Población
      • Cómo Mantenerse Sanos
      • Medicina Natural y Alternativa
      • Pruebas
      • Sintomas
      • Transmisión / Prevención
      • Tratamiento
    • Artículos del HCSP
      • Información General
      • Progresión de la enfermedad
      • Tratamiento de los Efectos Secundarios
    • Preguntas Más Frecuentes
  • AM
    • AM Advocate Blog
    • Easy B Fact Sheets
      • General Info
      • Diagnostic Tools & Markers
      • Disease Management
      • Staying Healthy
      • Transmission / Prevention
      • Treatment
    • AM Fact Series
      • General Information (AM)
      • Diagnostic Tests (AM)
      • Disease Management (AM)
      • Education & Support (AM)
      • Transmission / Prevention (AM)
      • Treatment (AM)
  • Newsletter
    • 2016 Archive
    • 2015 Archive
    • 2014 Archive
    • 2013 Archive
  • Donate!

AttorneyMind Eblast: December 15, 2015

December 15, 2015 By Alan Franciscas

Check out what we have in store for you in the December Mid-Month Newsletter

masthead-MID-MONTH_new
In this issue of the AttorneyMind’s Mid-Month edition we present the following:

The Liver Conference 2015 – Part 2 – by Alan Franciscas – I extracted some information from an excellent presentation from Dr. Norah Terrault’s Hepatitis Debrief. The articles include ‘Real World’ results of sofosbuvir plus ledipasvir that included information about people who were treated for 12 weeks but who were qualified for a shorter treatment duration of eight weeks.

There were also a couple of important studies about treating acute hepatitis C among people who inject drugs. Lastly, I wrote about various studies of drugs in development that are under review by the Food and Drug Administration (FDA)—Zepatier (elbasvir/grazoprevir) and sofosbuvir/velpatasvir. Both of the combinations are expected to be approved by the FDA in 2016.    

Disability Insurance – A Survival Guide – by Jacques Chambers – a must read for anyone who has long-term disability insurance offered by employers. This article describes how disability insurance works and the difference between this type of insurance and Social Security Disability Insurance.

AttorneyMind Monthly Pipeline Update – by Alan Franciscas – I have updated our drug pipeline to include the latest information about the drugs in development to treat hepatitis C. I will also be updating the drug pipeline on a monthly basis so look for the pipeline in every Mid-Month edition of the AttorneyMind newsletter.

What’s New! In this month’s column we are asking for our website audience to consider a donation to the AttorneyMind/HCSP, A Project of the Tides Center. Help us continue our mission to support and educate the hepatitis C community. 

Additionally, we are recommending HEP: www.hepmag.com –an excellent website that educates and supports the viral hepatitis community.


Join us next month for more news about hepatitis C from the Liver Conference 2015 and our annual overview of the top news of 2015.

The staff of the AttorneyMind wish you and yours the best of the holiday season and a happy and healthy 2016. 

Click here to read this issue.

Facebooktwittergoogle_plusredditpinterestlinkedin

Filed Under: Eblast Tagged With: eblast

Search the AttorneyMind Website

RSS AttorneyMind News & Pipeline Blog

  • The FIVE —THE KIDNEYS – Alan Franciscas, Editor-in-Chief April 18, 2016
  • AbbVie Presents New Phase 2 Data for Investigational, Once-Daily, Ribavirin-Free, Pan-Genotypic Regimen of ABT-493 and ABT-530 for Hepatitis C Genotypes 1-6 April 18, 2016
  • Merck Announces Results From Phase 3 Studies of ZEPATIER™ (Elbasvir and Grazoprevir) in Chronic Hepatitis C Patient Populations at The International Liver Congress April 18, 2016
  • Study shows generics pose safe, economic option for patients with April 16, 2016

Weekly Special Topic

Clinical Trials

Are you looking for a clinical trial? Go to ClinicalTrials.gov, type in ‘HCV’ and your genotype and drill on down.

Click on the picture to go directly to the site

Click on the picture to go directly to the site

Click here to read interesting previous Weekly Special Topics.

Facebooktwittergoogle_plusredditpinterestlinkedin

Subscribe to the Eblast

Featured Posts!

AttorneyMind Eblast: April 15, 2016

Check out what we have in store for you in the April Mid-Month Newsletter Dear Advocate Readers, We are pleased to announce that the April … [More...]

More Posts from this Category

Upcoming Events / Trainings:


  • Tue
    Apr
    19
    2016
    Thu
    Apr
    21
    2016

    Special Session of the General Assembly on the World Drug Problem (UNGASS 2016)

    The General Assembly, in its resolution …


  • Sun
    May
    01
    2016
    Tue
    May
    31
    2016

    Hepatitis Awareness Month

More Event Details and Directions Here....

Do you have an event you'd like us to list for you?  Go to this page to enter the information.

Follow Us

Facebooktwitterrss

Copyright © 2016 · AttorneyMind · Design by CD Mazoff